Company news
Theralase Technologies Inc. news in 2020
Theralase Technologies Inc.'s news releases, calls and decks from 2020, newest first.
University of British Columbia Launched as Newest Clinical Study Site for Phase II Non-Muscle Invasive Bladder Cancer Clinical Study
December 7, 2020
CORRECTION: Theralase Releases 3Q2020 Financial Statements
November 27, 2020
Theralase Release 3Q2020 Financial Statements
November 27, 2020
Theralase Granted FDA Fast Track Designation for NMIBC Phase II Clinical Study
November 23, 2020
Theralase Technology Demonstrates High Kill Rate of Coronavirus (BSL-2)
November 13, 2020
Theralase Releases Quarterly Newsletter
October 26, 2020
Theralase Provides Update on Bladder Cancer Study
September 24, 2020
Theralase Provides Update on Voting Procedures for Shareholder Meeting
September 24, 2020
Theralase Release 2Q2020 Financial Statements
August 28, 2020
Theralase Amends the Company's Standard By-Laws
August 19, 2020
Theralase Signs Agreement with University of Manitoba to Commence Development of Coronavirus Vaccine and Therapy
August 19, 2020
Canadian Clinical Study Sites Re-Commence Bladder Cancer Study
August 12, 2020
Theralase Reports on Phase II Non-Muscle Invasive Bladder Cancer ("NMIBC") Clinical Study ("Study II") Progress
July 30, 2020
Theralase Announces Management Information Circular and Annual General Meeting Postponement Due to COVID-19
June 30, 2020
Theralase Release 1Q2020 Financial Statements
May 29, 2020
Theralase Receives FDA IND Authorization
May 19, 2020
Theralase Releases 2019 Financial Results
April 29, 2020
Theralase Provides Company Update on Phase II Bladder Cancer Clinical Study
March 20, 2020
Theralase Advances Its Pivotal Phase II Non-Muscle Invasive Bladder Cancer Study with a New Clinical Study Site in Nova Scotia
February 25, 2020
Theralase Technologies Awarded 2020 TSX Venture 50
February 20, 2020
Theralase Granted US Patent for Multiwavelength Photodynamic Therapy
January 27, 2020
Theralase Wins Precedent-Setting Lawsuit Against Anonymous Individuals for Posting Defamatory Comments Online
January 16, 2020
View from the C-Suite: Shawn Shirazi, Chief Executive Officer, Theralase Technologies Inc., tells his company's story. Filmed on December 18, 2019
January 8, 2020